Rutabaga Capital Management’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-29,731
| Closed | -$974K | – | 48 |
|
|
2022
Q2 | $974K | Sell |
29,731
-17,400
| -37% | -$550K | 0.78% | 28 |
|
|
2022
Q1 | $1.24M | Hold |
47,131
| – | – | 0.78% | 36 |
|
|
2021
Q4 | $1.12M | Sell |
47,131
-53,300
| -53% | -$1.32M | 0.74% | 39 |
|
|
2021
Q3 | $2.52M | Sell |
100,431
-15,750
| -14% | -$401K | 1.22% | 34 |
|
|
2021
Q2 | $3.02M | Hold |
116,181
| – | – | 1.31% | 33 |
|
|
2021
Q1 | $2.98M | Sell |
116,181
-4,450
| -4% | -$114K | 1.37% | 32 |
|
|
2020
Q4 | $2.42M | Sell |
120,631
-48,112
| -29% | -$942K | 1.45% | 34 |
|
|
2020
Q3 | $2.89M | Sell |
168,743
-23,900
| -12% | -$452K | 1.64% | 36 |
|
|
2020
Q2 | $4.2M | Sell |
192,643
-10,116
| -5% | -$232K | 2.3% | 19 |
|
|
2020
Q1 | $4.69M | Buy |
202,759
+6,550
| +3% | +$190K | 2.81% | 11 |
|
|
2019
Q4 | $6.47M | Sell |
196,209
-46,047
| -19% | -$1.48M | 2.49% | 15 |
|
|
2019
Q3 | $7.71M | Sell |
242,256
-152,223
| -39% | -$4.44M | 2.73% | 10 |
|
|
2019
Q2 | $10.1M | Sell |
394,479
-83,963
| -18% | -$2.14M | 2.89% | 19 |
|
|
2019
Q1 | $12.1M | Buy |
478,442
+115,575
| +32% | +$3.45M | 3.36% | 10 |
|
|
2018
Q4 | $12.3M | Buy |
362,867
+102,791
| +40% | +$3.34M | 4.07% | 1 |
|
|
2018
Q3 | $9.27M | Buy |
+260,076
| New | +$9.18M | 2.13% | 20 |
|
Other funds holding NTUS
Rutabaga Capital Management's NTUS Position: Q3 2022 in Review
Rutabaga Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 29,731 shares — an estimated $974K sold.
Rutabaga Capital Management first reported a position in NTUS in Q3 2018 and held it in 16 quarters. The position peaked at $12.3M in Q4 2018. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Rutabaga Capital Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Rutabaga Capital Management sold 29,731 Natus Medical Inc shares in Q3 2022, an estimated $974K.
- Rutabaga Capital Management first reported a position in Natus Medical Inc in Q3 2018 and held it in 16 quarters.
- Rutabaga Capital Management's Natus Medical Inc position peaked at $12.3M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Rutabaga Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.